Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC) concluded
The global, double-blind, placebo-controled Phase 3 TransportNPC™ study (CTD-TCNPC-301) enroled 94 patients with NPC, ranging in age from 3 to
A forum for researchers, students and applicants in the field of cyclodextrin technology
The global, double-blind, placebo-controled Phase 3 TransportNPC™ study (CTD-TCNPC-301) enroled 94 patients with NPC, ranging in age from 3 to
Researchers from the United States 🇺🇸 and Canada 🇨🇦 developed hydrophilic, membrane-active nanoantibiotics by grafting polymer brushes onto cyclodextrin and
Surface functionalization of metallic implants is widely explored to enhance their performance and functionality. In this study, multifunctional hydrogel coatings
The global, double-blind, placebo-controled Phase 3 TransportNPC™ study (CTD-TCNPC-301) enroled 94 patients with NPC, ranging in age from 3 to
Researchers from the United States 🇺🇸 and Canada 🇨🇦 developed hydrophilic, membrane-active nanoantibiotics by grafting polymer brushes onto cyclodextrin and
Surface functionalization of metallic implants is widely explored to enhance their performance and functionality. In this study, multifunctional hydrogel coatings
When cyclodextrin meets brewer’s yeast Non-alcoholic beer sales keep growing, but one complaint remains: the foam collapses too fast. Without
The scientific program of the 22nd International Cyclodextrin Symposium (ICS-22) has been published on the website. The conference will take
From curcuminoid solubilization to potential boron neutron capture therapy for Alzheimer’s disease What if a cyclodextrin could help take a
The increasing popularity of oat milk is hindered by its inferior foaming performance, particularly as “clean-label” requirements restrict the use
When α-Cyclodextrin Meets 1-MCP: Supramolecular Chemistry Behind Fruit Storage Keeping harvested fruit fresh is, at its core, a race against
This review critically evaluates β-CD inclusion systems through a cross-scale framework linking host-guest recognition and complex stability with carrier architecture,
The 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027) will be held on September 30-October 2 2027 in Debrecen (Hungary)